Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2).
Wollenberg A, Blauvelt A, Guttman-Yassky E, Worm M, Lynde C, Lacour JP, Spelman L, Katoh N, Saeki H, Poulin Y, Lesiak A, Kircik L, Cho SH, Herranz P, Cork MJ, Peris K, Steffensen LA, Bang B, Kuznetsova A, Jensen TN, Østerdal ML, Simpson EL; ECZTRA 1 and ECZTRA 2 study investigators. Wollenberg A, et al. Among authors: steffensen la. Br J Dermatol. 2021 Mar;184(3):437-449. doi: 10.1111/bjd.19574. Epub 2020 Dec 30. Br J Dermatol. 2021. PMID: 33000465 Free PMC article. Clinical Trial.
Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials.
Simpson EL, Pink AE, Blauvelt A, Gooderham M, Armstrong AW, Worm M, Katoh N, Peris K, Puig L, Barbarot S, Mark T, Steffensen LA, Tindberg AM, Wollenberg A. Simpson EL, et al. Among authors: steffensen la. Am J Clin Dermatol. 2023 Nov;24(6):939-952. doi: 10.1007/s40257-023-00806-3. Epub 2023 Sep 8. Am J Clin Dermatol. 2023. PMID: 37682422 Free PMC article.
Patient-oriented measures for phase 3 studies of tralokinumab for the treatment of atopic dermatitis (ECZTRA 1, 2, and 3).
Simpson EL, Wollenberg A, Soong W, Steffensen LA, Kurbasic A, Schneider S, Zoidis J, Silverberg JI. Simpson EL, et al. Among authors: steffensen la. Ann Allergy Asthma Immunol. 2022 Nov;129(5):592-604.e5. doi: 10.1016/j.anai.2022.07.007. Epub 2022 Jul 14. Ann Allergy Asthma Immunol. 2022. PMID: 35843520 Free article. Clinical Trial.
Geographical differences in thrombolysis treatment for acute ischaemic stroke.
Busund K, Steffensen LH, Hauan A, Mathiesen EB, Eltoft A. Busund K, et al. Among authors: steffensen lh. Tidsskr Nor Laegeforen. 2024 Dec 16;144(15). doi: 10.4045/tidsskr.24.0020. Print 2024 Dec 17. Tidsskr Nor Laegeforen. 2024. PMID: 39692653 Free article. English, Norwegian.
Corrigendum: Selective inhibition of soluble tumor necrosis factor signaling reduces abdominal aortic aneurysm progression.
Griepke S, Grupe E, Lindholt JS, Fuglsang EH, Steffensen LB, Beck HC, Larsen MD, Bang-Møller SK, Overgaard M, Rasmussen LM, Lambertsen KL, Stubbe J. Griepke S, et al. Among authors: steffensen lb. Front Cardiovasc Med. 2024 Aug 19;11:1466614. doi: 10.3389/fcvm.2024.1466614. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39224753 Free PMC article.
63 results